Open AccessTocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)
Author(s) -
Mariam Naqvi,
P. Zakowski,
Lindsey Glucksman,
Sarah Smithson,
Richard M. Burwick
Publication year - 2020
Publication title -
obstetrics and gynecology (new york. 1953. online)/obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.664
H-Index - 220
eISSN - 1873-233X
pISSN - 0029-7844
DOI - 10.1097/aog.0000000000004050
Subject(s) - medicine , tocilizumab , pregnancy , covid-19 , coronavirus , gestation , hydroxychloroquine , obstetrics , pediatrics , disease , infectious disease (medical specialty) , genetics , biology
There are limited data regarding treatment options for pregnant women with severe coronavirus disease 2019 (COVID-19).